Tradestie Institutional Equity Comparison Engine
ABVX vs CONX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVX Overall Edge
ABVX Captures Institutional Edge (3โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABVX trades at N/M Forward P/E with -6270.4% operating margin (-6.8% YoY revenue) versus CONX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CONX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVX N/M vs CONX N/M Fwd P/E
Growth & Margin Winner
ABVX
Op Margin -6270.4% vs N/A ยท YoY -6.8% vs N/A
Momentum & Technical Winner
ABVX
1Y -17.1% vs -89.0% ยท 52W Pos 18% vs 0%
Options & Structure Winner
ABVX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ABVX
NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$83.61
-4.53% 1D
Market Cap
$7.7B
1M Return
-5.13%
1Y Return
-17.14%
Forward P/E
N/M
Unified AI Score
55.3 / 100
HOLD
Tech 42.0
Fund 48.0
Flow 50.0
Mom 50.0
CONX
US Equity
CONX
Institutional Equity
$2.66
-11.75% 1D
Market Cap
N/A
1M Return
-54.66%
1Y Return
-88.97%
Forward P/E
N/M
Unified AI Score
42.0 / 100
HOLD
Tech 25.0
Fund 54.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVX -17.14%
CONX -88.97%
Spread: +62.99 pp (ABVX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVX TTM Op. Margin: -6270.4%
CONX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs CONX. Trailing 12-month operating profitability (ABVX -6270.4% vs CONX N/A) and valuation multiples (ABVX N/M vs CONX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVX | CONX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.7B | N/A | Larger Scale | ABVX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -6.8% | N/A | Higher Growth | ABVX |
| Operating Margin (TTM) Profitability | -6270.4% | N/A | Higher Margin | ABVX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ABVX |
| Return on Equity (ROE) Capital Efficiency | -252.3% | N/A | Higher ROE | ABVX |
| 52-Week Range Position Momentum | 18% ($70โ$149) | 0% ($3โ$28) | Stronger Trend | ABVX |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 49% Vol | 4.88ฮฒ ยท 135% Vol | Lower Realized Risk | ABVX |
| Unified Institutional Score Composite Signal | 55.3 / 100 (HOLD) | 42.0 / 100 (HOLD) | Higher Composite | ABVX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVX vs CONX Buy Guide
ABVX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
CONX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVX nor CONX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.